IL307980A - Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female - Google Patents
Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating femaleInfo
- Publication number
- IL307980A IL307980A IL307980A IL30798023A IL307980A IL 307980 A IL307980 A IL 307980A IL 307980 A IL307980 A IL 307980A IL 30798023 A IL30798023 A IL 30798023A IL 307980 A IL307980 A IL 307980A
- Authority
- IL
- Israel
- Prior art keywords
- depressive disorder
- major depressive
- neuroactive steroid
- postpartum depression
- lactating female
- Prior art date
Links
- 201000009916 Postpartum depression Diseases 0.000 title 1
- 208000024714 major depressive disease Diseases 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181807P | 2021-04-29 | 2021-04-29 | |
| PCT/US2022/026908 WO2022232494A1 (en) | 2021-04-29 | 2022-04-29 | Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL307980A true IL307980A (en) | 2023-12-01 |
Family
ID=81748326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL307980A IL307980A (en) | 2021-04-29 | 2022-04-29 | Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240216396A1 (en) |
| EP (1) | EP4329769A1 (en) |
| JP (1) | JP2024515830A (en) |
| CN (1) | CN117580580A (en) |
| AU (1) | AU2022267304A1 (en) |
| CA (1) | CA3217866A1 (en) |
| IL (1) | IL307980A (en) |
| MX (1) | MX2023012728A (en) |
| WO (1) | WO2022232494A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL304912A (en) | 2012-08-21 | 2023-10-01 | Sage Therapeutics Inc | Methods of treating epilepsy or status epilepticus |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (en) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | Neuroactive steroids, compositions, and uses thereof |
| SI3224269T1 (en) | 2014-11-27 | 2020-10-30 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2019113494A1 (en) | 2017-12-08 | 2019-06-13 | Sage Therapeutics, Inc. | Deuterated 21 -[4-cyano-pyrazol-1 -yl]-19-nor-pregan-3. alpha-ol-20-one derivatives for treating cns disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102239541B1 (en) | 2013-04-17 | 2021-04-14 | 세이지 테라퓨틱스, 인크. | 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof |
| PE20190915A1 (en) | 2016-08-23 | 2019-06-26 | Sage Therapeutics Inc | A 19-NOR-C21-N-PIRAZOLYL C3,3-DISUSTITUTED CRYSTALINE STEROID |
| MA52894A (en) * | 2018-06-12 | 2021-04-21 | Sage Therapeutics Inc | 19-NOR STEROID C21-N-PYRAZOLYL DISUBSTITUTED IN C3,3 AND METHODS FOR USING THE SAME |
| CN113939298A (en) * | 2018-12-14 | 2022-01-14 | 普拉西斯精密医药公司 | Methods for treating depression |
| TW202220667A (en) | 2020-07-20 | 2022-06-01 | 美商賽吉醫療公司 | Formulations of 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
-
2022
- 2022-04-29 MX MX2023012728A patent/MX2023012728A/en unknown
- 2022-04-29 CA CA3217866A patent/CA3217866A1/en active Pending
- 2022-04-29 US US18/557,705 patent/US20240216396A1/en active Pending
- 2022-04-29 IL IL307980A patent/IL307980A/en unknown
- 2022-04-29 JP JP2023566515A patent/JP2024515830A/en active Pending
- 2022-04-29 WO PCT/US2022/026908 patent/WO2022232494A1/en active Application Filing
- 2022-04-29 EP EP22724194.0A patent/EP4329769A1/en active Pending
- 2022-04-29 CN CN202280045723.6A patent/CN117580580A/en active Pending
- 2022-04-29 AU AU2022267304A patent/AU2022267304A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023012728A (en) | 2023-11-08 |
| US20240216396A1 (en) | 2024-07-04 |
| CN117580580A (en) | 2024-02-20 |
| CA3217866A1 (en) | 2022-11-03 |
| EP4329769A1 (en) | 2024-03-06 |
| WO2022232494A1 (en) | 2022-11-03 |
| JP2024515830A (en) | 2024-04-10 |
| AU2022267304A1 (en) | 2023-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL307980A (en) | Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating female | |
| GB2595517B (en) | Methods and apparatuses for synchronization in a multi-AP coordination | |
| IL292040A (en) | Devices and methods for modulating immune system activity in a cancer patient and treating cancer | |
| GB2615910B (en) | Turbofan and air-conditioning apparatus | |
| KR102193175B9 (en) | Stem cell-derived exosomes with pain control factors and uses thereof | |
| IL298992A (en) | C-type natriuretic peptides and methods thereof in treating cancer | |
| EP4165067A4 (en) | C-type natriuretic peptides and methods thereof in treating acute lung injury | |
| GB2610271B (en) | Modeling devices used in guided bone and tissue regeneration | |
| GB2588994B (en) | Combar for skin and hair treatment | |
| SG11202107336YA (en) | A biowaste treatment system and a method of biowaste treatment in association therewith | |
| GB2616093B (en) | Methods and apparatuses for synchronization in a multi-AP coordination | |
| GB2607397B (en) | Rolling plastic-forming device and method for internal thread | |
| HUE060482T2 (en) | Parapoxvirus for conditioning and treatment of coronavirus infections | |
| IL289591A (en) | Hla-h in medicine and diagnostics | |
| IL251684A0 (en) | Device and method for creating a channel in soft tissue | |
| PL4198001T3 (en) | Pt-biphenyl-iodine-complex and pt-biphenyl-bromine complex | |
| IL307464A (en) | Ofatumumab for treating multiple sclerosis in asian patients | |
| EP4157421A4 (en) | Multi-lumen manifold and method of operating a multi-lumen manifold | |
| IL274192A (en) | Three-way valve and patient circuit adaptor for a medical ventilator | |
| IL315174A (en) | Abiraterone decanoate prodrugs and use in therapy | |
| GB202103560D0 (en) | Means and method for controlling devices in a microgrid | |
| GB2608445B (en) | Divide/square-root pipeline and method | |
| IL309030A (en) | Apparatus for improving hydration and / or reducing particle size of a product and a method of use thereof | |
| ZA202107319B (en) | Method for preventing and treating scab disease | |
| GB202019762D0 (en) | Compounds for use in treatment and prophylaxis |